Marker Therapeutics MRKR
NASDAQ MRKR
$1.05 -0.02 (-1.87%)
At close: Oct 1, 2026 · 4:00 PM EDT

Marker Therapeutics (MRKR) Other Non-Current Liabilities (2011 - 2015)

Updated

Marker Therapeutics (MRKR) recorded Other Non-Current Liabilities of $16.84 million in Q4 2015.

Analysis

Marker Therapeutics (MRKR) Other Non-Current Liabilities (2011 - 2015) Analysis & Trends

Starting with Q4 2011, Marker Therapeutics' Other Non-Current Liabilities history includes 5 quarters.

  • Annual Other Non-Current Liabilities has a four-year compound annual growth rate of 89.1% (FY2011 to FY2015).
  • Across earlier years, Other Non-Current Liabilities came in at $677,086 in FY2012 (-48.6%) and $1.32 million in FY2011.
  • The Q4 2015 figure is the lowest quarterly Other Non-Current Liabilities since Q1 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Marker Therapeutics 17.87 Mn -42.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 16.84 Mn
Mar 31, 2013 462,293.00
Dec 31, 2012 677,086.00
Sep 30, 2012 871,858.00
Dec 31, 2011 1.32 Mn
API Access

Marker Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=MRKR&period=max&api_key=YOUR_API_KEY